Aptar Pharma Continues Global Expansion with North America Capacity Extension at Congers, New York Site
Aptar Pharma, part of AptarGroup, Inc., a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced the next phase of its global capacity expansion plan in North America, at its Aptar Congers, New York site.
- Aptar Pharma, part of AptarGroup, Inc., a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced the next phase of its global capacity expansion plan in North America, at its Aptar Congers, New York site.
- This investment will help Aptar meet the growing prescription and consumer healthcare customer demand for proprietary drug delivery systems in North America.
- Manufacturing capabilities at the Congers facility will be further expanded to offer even more innovative product solutions and increased production capacity to Aptar Pharma customers in North America.
- “Our Aptar Pharma business in North America has shown robust growth in recent years, with increasing customer demand across all product lines,” commented Gael Touya, President, Aptar Pharma.